Re: News from a Chinese/Japenese Article about Zenith

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fouremm

Rank: President [?]

Points: 3330 [?]

Votes: 34 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: News from a Chinese/Japenese Article about Zenith

in response to

Re: News from a Chinese/Japenese Article about Zenith

SanFrancisco99

posted on Oct 26, 2016 04:57PM

Just to add a little speculative fuel :) Enzalutamide (for mCRPC) is owned by Astellas Pharma which is a large Japanese pharma. Nice find LongRVXer

5 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply